EIF2AK3 and early-onset autosomal dominant Alzheimer disease: Further support that the PERK branch of the UPR might be a promising therapeutic target comes from studies investigating ER stress related diseases, including Alzheimer’s Disease (AD), amyotrophic lateral disease (ALS), Parkinson’s Disease, and prion diseases [151,152].